Immunophotonics is developing inCVAX, an in situ autologous cancer vaccine, which combines thermal laser with immunotherapy for the treatment of metastatic cancers. Promising results have emerged in the preclinical and early clinical studies.

© 2015 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription